Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Stock Crosses Below 200 Day Moving Average – What’s Next?

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) shares crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $33.47 and traded as low as $31.40. Tema Cardiovascular and Metabolics ETF shares last traded at $31.79, with a volume of 12,296 shares changing hands.

Tema Cardiovascular and Metabolics ETF Price Performance

The firm has a market capitalization of $78.84 million, a PE ratio of 32.89 and a beta of 0.93. The business has a 50-day simple moving average of $33.31 and a 200-day simple moving average of $33.47.

Institutional Investors Weigh In On Tema Cardiovascular and Metabolics ETF

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. increased its holdings in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 20.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 153,090 shares of the company’s stock after buying an additional 26,130 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for about 1.4% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 20th largest position. Sterling Investment Advisors Ltd. owned approximately 6.03% of Tema Cardiovascular and Metabolics ETF worth $5,104,000 as of its most recent SEC filing.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.